Zacks Investment ResearchTue, 05 May 2026 22:16:23 GMTDianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue EstimatesDNTH+1.45%
The Motley FoolSun, 19 Apr 2026 13:08:22 GMTDianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000DNTH+1.45%
The Motley FoolMon, 06 Apr 2026 19:27:17 GMTDianthus Therapeutics CFO Sells $9.5 Million in StockDNTH+1.45%
Zacks Investment ResearchWed, 01 Apr 2026 08:55:37 GMTStrength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?DNTH+1.45%
The Motley FoolWed, 18 Mar 2026 17:48:40 GMTBiotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million ExitDNTH+1.45%
Seeking AlphaTue, 10 Mar 2026 18:08:54 GMTDianthus Therapeutics: Go Decision For CIDP Program Warrants Continued Buy RatingDNTH+1.45%
Seeking AlphaTue, 10 Mar 2026 00:47:57 GMTDianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP TranscriptDNTH+1.45%
Investors Business DailyMon, 09 Mar 2026 16:07:19 GMTDianthus Therapeutics Has Appreciated 13-Fold Over Two Years. What's Going On?DNTH+1.45%
Zacks Investment ResearchMon, 09 Mar 2026 13:26:08 GMTDianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue EstimatesDNTH+1.45%
BenzingaMon, 09 Mar 2026 13:22:15 GMTDianthus Therapeutics Stock Rallies—Rare Disease Study Success Fuels OptimismDNTH+1.45%
Zacks Investment ResearchThu, 05 Mar 2026 14:46:12 GMTDianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar?DNTH+1.45%
Seeking AlphaMon, 16 Feb 2026 19:47:38 GMTDianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 TranscriptDNTH+1.45%
